TABLE 2.
Compound | Dose | Dosing regimena | Scrapie infection route | Incubation periods (days) | Mean ± SD |
---|---|---|---|---|---|
None | None | i.p. | 85, 76, 93, 91, 83, 83, 85, 97 | 86.6 ± 6.7 | |
Cu(II)PcS4 | 25 mg/kg, i.p. | M, W, F for 6 wk starting 2 wk prior to inoculation | i.p. | 335, 354, 353, 365, 396, 294, 378, 332 | 350.9 ± 31.2 |
Cu(II)PcS4 | 25 mg/kg, i.p. | M, W, F until death starting 50 days after inoculation | i.p. | 98, 97, 83, 91, 87, 83, 87, 82, 83 | 87.9 ± 6.2 |
Noneb | 50 μl PBS, i.c. | Days 14, 21, 28, 35, 42 | i.c. | 42, 42, 44, 44, 45, 45, 46, 46, 46, 47, 47, 48, 51, 52, 53 | 46.5 ± 3.3 |
Cu(II)PcS4 | 50 μl 0.5 mg/ml, i.c. | M, W, F for 3 wk starting 2 wk after inoculationc | i.c. | 51, 42, 51, 58, 79, 48, 45, 48 | 52.8 ± 11.6 |
Cu(II)PcS4 | 50 μl 0.5 mg/ml, i.c. | Days 14, 21, 28, 35, 42 | i.c. | 41, 47, 46, 47, 44, 47, 45, 45 | 45.3 ± 2.1 |
Fe(III)TSPb | 50 μl 0.5 mM, i.c. | Days 14, 21, 28, 35, 42 | i.c. | 53, 54, 58, 59, 59, 61, 62, 63, 63, 64, 65, 65, 71 | 61.3 ± 4.8 |
Mn(III)TSP | 50 μl 0.5 mM, i.c. | Days 14, 21, 28, 35, 42 | i.c. | 46, 47, 48, 48, 48, 49, 50, 51 | 48.4 ± 1.6 |
M, Monday; W, Wednesday; F, Friday.
Combined data from two separate but identically conducted experiments.
Treatments were stopped at 3 weeks due to observed toxicity.